bookmark

The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder | Evidence-Based Medicine


Description

A Cochrane systematic review on immediate-release methylphenidate for adults with attention deficit hyperactivity disorder (ADHD) was withdrawn from the Cochrane Library on 26 May 2016 after substantial criticism of its methods and flawed conclusions... We provide a summary of the criticism that led to the withdrawal. Open Access Article

Preview

Tags

Users

  • @sssftlibrary

Comments and Reviews